Denosumab delays the time to first skeletal-related event in patients with myelomaConferences, MyelomaJune 5, 2017
Patients and cancer experts launch a joint vision for improving cancer outcomes in EuropeMyeloma, Patient evidenceJanuary 12, 2017
Addition of daratumumab to bortezomib and dexamethasone in patients with relapsed or refractory shows promising results in a phase III trialMyelomaOctober 13, 2016
Innovative Medicines Initiative (IMI) approves € 40 million project for better care of patients with haematologic malignanciesMyelomaJanuary 9, 2017
MPE to hold the “EHA 2016 Highlights in myeloma” webinar on 14th JulyConferences, MPE, MyelomaJune 24, 2016
MPE encourages EMA to review its negative recommendation for ixazomibAccess, MPE, MyelomaAugust 16, 2016
EMA reconsiders and gives its positive opinion for the approval of ixazomibAccess, MyelomaSeptember 17, 2016
Myeloma patient survey to inform development of personalised medicine toolMPE, Myeloma, Patient evidenceMarch 26, 2018
